News

25. April 2017

Probiodrug AG

Probiodrug to attend and present at International Conferences in May 2017

20. April 2017

InvenSor GmbH

Energietag bei Bühler Motor am 19.06.2017 in Nürnberg

Energieeffizienz in der Produktion steigern

10. April 2017

Probiodrug to present at Huntington's Disease Therapeutics Conference

The Glutaminyl Cyclase (QC) inhibitor PQ912 demonstrates beneficial effects in a preclinical Huntington's disease model

7. April 2017

Probiodrug AG

Last Patient Last Visit (LPLV) reached in the SAPHIR Study, a Phase 2 trial with the Glutaminyl Cyclase (QC) inhibitor PQ912 in early Alzheimer's Disease (AD)

6. April 2017

Digital Republic Media Group GmbH

bmp begrüßt Übernahme von Gamesrocket durch IBG-Beteiligung Digital Republic Media Group

  • durch den Verbund entsteht der größte deutsche Onlinestore für digitale Games
3. April 2017

Probiodrug AG

Probiodrug to attend International Conferences in April 2017

30. März 2017

Probiodrug reports full year 2016 financial results

SAPHIR, the Phase 2a study of PQ912 as a novel treatment for Alzheimer's disease fully enrolled

Favourable results of chronic toxicology studies with PQ912 announced

Promising combination data of PQ912 and a pGlu Abeta specific antibody generated

Successful capital raise of...

28. März 2017

Tesvolt GmbH

bmp investiert Wachstumskapital der IBG-Fonds aus Sachsen-Anhalt in Batteriespeicherhersteller Tesvolt

28. März 2017

Probiodrug AG

Probiodrug to present at Alzheimer's and Parkinson's Diseases Congress

New results of a double pronged-approach to target the neurotoxic amyloid beta species pGlu-Abeta, and an evaluation of new biomarkers in cerebrospinal fluid (CSF) from AD patients

23. März 2017

Probiodrug AG

Probiodrug AG to Publish its Full Year 2016 Results on 30 March 2017

Seiten